The need for calcium channels in cell proliferation

Recent Patents on Anti-Cancer Drug Discovery

Volumn 8, Issue 1, 2013, Pages 4-17

  Capiod, Thierry ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Calcium channels; Cell cycle; Cell proliferation; Cyclins; Mitosis; ORAI; SERCA; TRPC

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 3; CM 2489; CYCLIN DEPENDENT KINASE; DEFEROXAMINE; EGTAZIC ACID; GROWTH FACTOR; IRON; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 2; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR 6;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; DNA SYNTHESIS; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HUMAN; LIPID RAFT; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; STORE OPERATED CALCIUM ENTRY; TUMOR CELL; UNSPECIFIED SIDE EFFECT;

EID: 84875428911     PISSN: 15748928     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574892811308010004     Document Type: Review

References (226)

1. Carafoli E. Calcium signaling: A tale for all seasons. Proc Nat Acad Sci USA 2002; 99(3): 1115-1122.
2. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4(7): 517-529.
3. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000; 1(1): 11-21.
4. Berridge MJ. Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 2009; 1793(6): 933-940.
5. 2+ signalling. FEBS J 2009; 276(7): 1800-1816.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-674.
7. Parekh AB, Putney JW, Jr. Store-operated calcium channels. Physiol Rev 2005; 85(2): 757-810.
8. Putney JW, Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986; 7(1): 1-12.
9. 2+ entry. J Biol Chem 2006; 281(47): 35855-35862.
10. 2+ store depletion. Proc Nat Acad Sci USA 2007; 104(22): 9301-9306.
11. 2+ entry: Local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol 2006; 174(6): 815-825.
12. Xu P, Lu J, Li Z, Yu X, Chen L, Xu T. Aggregation of STIM1 underneath the plasma membrane induces clustering of Orai1. Bio-chem Biophys Res Comm 2006; 350(4): 969-976.
13. Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, et al. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 2006; 8(7): 771-773.
14. Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, Gill DL. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 2006; 281(30): 20661-20665.
15. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992; 355(6358): 353-356.
16. 2+ signaling just got STIMy: An update on STIM1 activated TRPC channels. Front Biosci 2012; 17: 805-823.
17. Gudermann T, Hofmann T, Mederos y Schnitzler M, Dietrich A. Activation, subunit composition and physiological relevance of DAG-sensitive TRPC proteins. Novartis Foundation Symposium 2004; 258: 103-18; discussion 18-22, 55-9, 263-266.
18. Mignen O, Shuttleworth TJ. I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. J Biol Chem 2000; 275(13): 9114-9119.
19. 2+-selective ARC channel is a pentameric assembly of Orai1 and Orai3 subunits. J Physiol 2009; 587(Pt 17): 4181-4197.
20. Shuttleworth TJ, Mignen O. Calcium entry and the control of calcium oscillations. Biochem Soc Trans 2003; 31(Pt 5): 916-919.
21. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 2007; 42(2): 145-156.
22. Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol 2010; 28: 491-533.
23. Shaw PJ, Feske S. Physiological and pathophysiological functions of SOCE in the immune system. Front Biosci (Elite Ed) 2012; 4: 2253-2268.
24. 2+ entry in the immune system and beyond. Immunol Rev 2009; 231(1): 189-209.
25. Roos, J., Stauderman, K.A., Velicelebi, G., DiGregorio, P.J., Ohl-sen, K.L. Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use. US7645588 (2010).
26. Lockyer, P., Lockyer, J. Methods for detecting calcium ion influx. US20080160536 (2008).
27. Monteith, G.R., Roberts-Thomson, S.J., McAndrew, D.V. Target for breast cancer therapy and/or diagnosis. US20100119518 (2010).
28. Whitten, J.P., Pel, Y., Cao, J., Wang, Z., Rogers, E., Dyck, B., Grey, J. Compounds that modulate intracellular calcium. US20110263612 (2011).
29. Muthuppalaniappan, M., Viswanadhu, S., Varanasi, K.V., Merika-pudi, G.S., Vakkalanka, S.K. Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer. US20110112058 (2011).
30. Stewart, J.M. Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity. US20110071089 (2011).
31. Ingher, D.E., Thodeti, C.K. Methods of modulating angiogenesis via TRPV4. US20110150894 (2011).
32. Rao, A., Hogan, P.G., Sharma, S. Regulators of NFAT and/or store-operated calcium entry. US8048864 (2011).
33. Roberts-Thomson SJ, Peters AA, Grice DM, Monteith GR. ORAI-mediated calcium entry: Mechanism and roles, diseases and pharmacology. Pharmacol Ther 2010; 127(2): 121-130.
34. Shapovalov G, Lehen'kyi V, Skryma R, Prevarskaya N. TRP channels in cell survival and cell death in normal and transformed cells. Cell Calcium 2011; 50(3): 295-302.
35. Kohn, C.H., Liotta, L.A., Felder, C.C. Signal transduction inhibitor compounds. US5359078 (1994).
36. Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, et al. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 2008; 60(2): 200-207.
37. Boynton AL, Whitfield JF, Isaacs RJ. The different roles of serum and calcium in the control of proliferation of BALB/c 3T3 mouse cells. In vitro 1976; 12(2): 120-123.
38. Hazelton B, Mitchell B, Tupper J. Calcium, magnesium, and growth control in the WI-38 human fibroblast cell. J Cell Biol 1979; 83(2 Pt 1): 487-498.
39. Whitfield JF, Boynton AL, MacManus JP, Sikorska M, Tsang BK. The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 1979; 27(3): 155-179.
40. Tani D, Monteilh-Zoller MK, Fleig A, Penner R. Cell cycle-dependent regulation of store-operated I(CRAC) and Mg2-nucleotide-regulated MagNuM (TRPM7) currents. Cell Calcium 2007; 41(3): 249-260.
41. Boynton AL, Whitfield JF, Isaacs RJ, Tremblay R. The control of human WI-38 cell proliferation by extracellular calcium and its elimination by SV-40 virus-induced proliferative transformation. J Cell Physiol 1977; 92(2): 241-247.
42. 2+/calmodulin is involved in growth factor-induced retinoblastoma gene product phosphorylation in human vascular endothelial cells. FEBS Lett 1992; 306(2-3): 173-175.
43. Reddy GP. Cell cycle: Regulatory events in G1-->S transition of mammalian cells. J Cell Biochem 1994; 54(4): 379-386.
44. Takuwa N, Zhou W, Takuwa Y. Calcium, calmodulin and cell cycle progression. Cell Signal 1995; 7(2): 93-104.
45. Whitfield JF. Calcium signals and cancer. Crit Rev Oncog 1992; 3(1-2): 55-90.
46. Boynton AL. Calcium and epithelial cell proliferation. Miner Elec-trol Metab 1988; 14(1): 86-94.
47. Takuwa N, Zhou W, Kumada M, Takuwa Y. Ca(2+)-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J Biol Chem 1993; 268(1): 138-145.
48. Swierenga SH, Whitfield JF, Karasaki S. Loss of proliferative calcium dependence: Simple in vitro indicator of tumorigenicity. Proc Natl Acad Sci USA 1978; 75(12): 6069-6072.
49. 2+ current, IL-2 production and activation in T lymphocytes. Br J Pharmacol 1994; 113(3): 861-8.
50. 2+ entry. Cancer Res 2000; 60(4): 1002-1008.
51. 2+/phospholipid-dependent kinase. Scand J Immunol 1986; 24(3): 283-290.
52. Panner A, Wurster RD. T-type calcium channels and tumor proliferation. Cell Calcium 2006; 40(2): 253-259.
53. Taylor JM, Simpson RU. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res 1992; 52(9): 2413-2418.
54. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 2008; 267(1): 116-124.
55. Enfissi A, Prigent S, Colosetti P, Capiod T. The blocking of capaci-tative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium 2004 12; 36(6): 459-467.
56. Parekh AB. Store-operated CRAC channels: Function in health and disease. Nature Rev 2010; 9(5): 399-410.
57. Girard S, Clapham D. Acceleration of intracellular calcium waves in Xenopus oocytes by calcium influx. Science 1993; 260(5105): 229-232.
58. Putney JW, Bird GS. Cytoplasmic calcium oscillations and store-operated calcium influx. J Physiol 2008; 586(13): 3055-3059.
59. Bird GS, Putney JW, Jr. Capacitative calcium entry supports calcium oscillations in human embryonic kidney cells. J Physiol 2005; 562(Pt 3): 697-706.
60. Van Breemen C, Farinas BR, Gerba P, McNaughton ED. Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res 1972; 30(1): 44-54.
61. Sneyd J, Tsaneva-Atanasova K, Yule DI, Thompson JL, Shuttle-worth TJ. Control of calcium oscillations by membrane fluxes. Proc Nat Acad Sci USA 2004; 101(5): 1392-1396.
62. Santella L. The role of calcium in the cell cycle: Facts and hypotheses. Biochem Biophys Res Commun 1998; 244(2): 317-324.
63. Steinhardt RA, Alderton J. Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 1988; 332(6162): 364-366.
64. Shuttleworth TJ, Thompson JL, Mignen O. STIM1 and the nonca-pacitative ARC channels. Cell Calcium 2007; 42(2): 183-191.
65. Burnstock G. Purinergic signalling: Past, present and future. Br J Med Biol Res 2009; 42(1): 3-8.
66. Burnstock G, Kennedy C. P2X receptors in health and disease. Adv Pharmacol 2011; 61: 333-372.
67. Nacher J, McEwen BS. The role of N-methyl-D-asparate receptors in neurogenesis. Hippocampus 2006; 16(3): 267-270.
68. Lory P, Bidaud I, Chemin J. T-type calcium channels in differentiation and proliferation. Cell Calcium 2006; 40(2): 135-146.
69. Lau YT, Wong CK, Luo J, Leung LH, Tsang PF, Bian ZX, et al. Effects of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers on the proliferation and cell cycle progression of embryonic stem cells. Pflugers Arch 2011; 461(1): 191-202.
70. Beech DJ. TRPC1: Store-operated channel and more. Pflugers Arch 2005; 451(1): 53-60.
71. 2+ entry and embryonic rat neural stem cell proliferation. J Neurosci 2005; 25(10): 2687-2701.
72. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 2008; 103(11): 1289-1299.
73. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 2002; 283(1): L144-L155.
74. Wu X, Zagranichnaya TK, Gurda GT, Eves EM, Villereal ML. A TRPC1/TRPC3-mediated increase in store-operated calcium entry is required for differentiation of H19-7 hippocampal neuronal cells. J Biol Chem 2004; 279(42): 43392-43402.
75. Woo JS, Cho CH, Kim do H, Lee EH. TRPC3 cation channel plays an important role in proliferation and differentiation of skeletal muscle myoblasts. Exp Mol Med 2010; 42(9): 614-627.
76. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 2009; 28(10): 1320-1328.
77. Antigny F, Girardin N, Frieden M. Transient receptor potential canonical channels are required for in vitro endothelial tube formation. J Biol Chem 2012; 287(8): 5917-5927.
78. Yang H, Mergler S, Sun X, Wang Z, Lu L, Bonanno JA, et al. TRPC4 knockdown suppresses epidermal growth factor-induced store-operated channel activation and growth in human corneal epithelial cells. J Biol Chem 2005; 280(37): 32230-32237.
79. Ding X, He Z, Shi Y, Wang Q, Wang Y. Targeting TRPC6 channels in oesophageal carcinoma growth. Expert Opin Ther Targets 2010; 14(5): 513-527.
80. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, Capiod T. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 2008; 47(6): 2068-2077.
81. Ge R, Tai Y, Sun Y, Zhou K, Yang S, Cheng T, et al. Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett 2009; 283(1): 43-51.
82. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 2006; 66(4): 2038-2047.
83. Wang Y, Yue D, Li K, Liu YL, Ren CS, Wang P. The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells. Asian J Androl 2010; 12(6): 841-852.
84. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, et al. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 2003; 284(2): C316-C330.
85. Leuner K, Kraus M, Woelfle U, Beschmann H, Harteneck C, Boehncke WH, et al. Reduced TRPC channel expression in psori-atic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS ONE 2011; 6(2): e14716.
86. Monet M, Lehen'kyi V, Gackiere F, Firlej V, Vandenberghe M, Roudbaraki M, et al. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 2010; 70(3): 1225-1235.
87. Nabissi M, Morelli MB, Amantini C, Farfariello V, Ricci-Vitiani L, Caprodossi S, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. Carcinogenesis 2010; 31(5): 794-803.
88. 2+ in human esophageal epithelial cells. Am J Physiol 2011; 301(1): G138-G147.
89. Gradilone SA, Masyuk TV, Huang BQ, Banales JM, Lehmann GL, Radtke BN, et al. Activation of Trpv4 reduces the hyperprolifera-tive phenotype of cystic cholangiocytes from an animal model of ARPKD. Gastroenterology 2010; 139(1): 304-314 e2.
90. 2+ channel expression. Biochem Biophys Res Commun 2004; 322(4): 1359-1363.
91. Schwarz EC, Wissenbach U, Niemeyer BA, Strauss B, Philipp SE, Flockerzi V, et al. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium 2006; 39(2): 163-173.
92. Bolanz KA, Hediger MA, Landowski CP. The role of TRPV6 in breast carcinogenesis. Mol cancer Ther 2008; 7(2): 271-279.
93. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 2009; 297(3): C493-C502.
94. 2+ entry pathway in human retinoblastoma cells. J Pharmacol Sci 2004; 95(4): 403-419.
95. 2+-sensitive Socs3a signaling in development and cancer. Dis Model Mech 2011; 4(2): 240-254.
96. Yee NS, Zhou W, Lee M. Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma. Cancer Lett 2010; 297(1): 49-55.
97. Yang ZH, Wang XH, Wang HP, Hu LQ. Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J An-drol 2009; 11(2): 157-165.
98. El Boustany C, Katsogiannou M, Delcourt P, Dewailly E, Prevar-skaya N, Borowiec AS, et al. Differential roles of STIM1, STIM2 and Orai1 in the control of cell proliferation and SOCE amplitude in HEK293 cells. Cell Calcium 2010; 47(4): 350-359.
99. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA, et al. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: Role in proliferation and migration. Faseb J 2009; 23(8): 2425-2437.
100. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J Cell Physiol 2011; 226(2): 542-551.
101. Cahalan MD. STIMulating store-operated Ca(2+) entry. Nat Cell Biol 2009; 11(6): 669-677.
102. Varnai P, Hunyady L, Balla T. STIM and Orai: The long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 2009; 30(3): 118-128.
103. Li J, Sukumar P, Milligan CJ, Kumar B, Ma ZY, Munsch CM, et al. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circ Res 2008; 103(8): e97-e104.
104. Darbellay B, Arnaudeau S, Konig S, Jousset H, Bader C, Demaurex N, et al. STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. J Biol Chem 2009; 284(8): 5370-5380.
105. El Hiani Y, Lehen'kyi V, Ouadid-Ahidouch H, Ahidouch A. Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways. Arch Biochem Biophys 2009; 486(1): 58-63.
106. 2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells. Am J Physiol 2012; 302(2): C405-C411.
107. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, et al. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 2001; 280(2): H746-H755.
108. Hou MF, Kuo HC, Li JH, Wang YS, Chang CC, Chen KC, et al. Orai1/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim Biophys Acta 2011; 1810(12): 1278-1284.
109. Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression. Adv Exp Med Biol 2011; 704: 947-967.
110. Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim Biophys Acta 2009; 1793(6): 953-958.
111. Bodding M. TRP proteins and cancer. Cell Signal 2007; 19(3): 617-624.
112. Feske S. CRAC channelopathies. Pflugers Arch 2010; 460(2): 417-435.
113. Feske S, Picard C, Fischer A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol 2010; 135(2): 169-182.
114. 2+ channels in vascular smooth muscle: Multiple functions. Cell Calcium 2006; 40(2): 221-230.
115. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 1996; 79(1): 14-19.
116. Bodding M. Reduced store-operated Ca(2+) currents in rat baso-philic leukaemia cells cultured under serum-free conditions. Cell Calcium 2001; 30(2): 141-150.
117. Kuang CY, Yu Y, Wang K, Qian DH, Den MY, Huang L. Knockdown of transient receptor potential Canonical-1 reduces the proliferation and migration of endothelial progenitor cells. Stem Cells Dev 2012; 21(3): 487-496.
118. Cai R, Ding X, Zhou K, Shi Y, Ge R, Ren G, et al. Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 2009; 125(10): 2281-2287.
119. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 2010; 102(14): 1052-1068.
120. Shi Y, Ding X, He ZH, Zhou KC, Wang Q, Wang YZ. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut 2009; 58(11): 1443-1450.
121. Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nar-geot J, et al. Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 2000; 478(1-2): 166-172.
122. Volpi M, Berlin RD. Intracellular elevations of free calcium induced by activation of histamine H1 receptors in interphase and mi-totic HeLa cells: Hormone signal transduction is altered during mitosis. J Cell Biol 1988; 107(6 Pt 2): 2533-2539.
123. 2+ stores are coupled in interphase but not mitosis. Cell Reg 1991; 2(11): 915-925.
124. Russa AD, Ishikita N, Masu K, Akutsu H, Saino T, Satoh Y. Micro-tubule remodeling mediates the inhibition of store-operated calcium entry (SOCE) during mitosis in COS-7 cells. Arch Histol Cytol 2008; 71(4): 249-263.
125. Smyth JT, Petranka JG, Boyles RR, DeHaven WI, Fukushima M, Johnson KL, et al. Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis. Nat Cell Biol 2009; 11(12): 1465-1472.
126. Yu F, Sun L, Machaca K. Orai1 internalization and STIM1 clustering inhibition modulate SOCE inactivation during meiosis. Proc Natl Acad Sci USA 2009; 106(41): 17401-17406.
127. 2+ channel Orai1 and its internalization during meiosis. J Cell Biol 2010; 191(3): 523-535.
128. 2+ entry during the cell cycle. J Cell Sci 2010; 123(Pt 13): 2155-2162.
129. 2+ entry: Evidence for a secretion-like coupling model. Cell 1999; 98(4): 487-499.
130. Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, et al. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci USA 2006; 103(28): 10660-10665.
131. Machaca K, Haun S. Induction of maturation-promoting factor during Xenopus oocyte maturation uncouples Ca(2+) store depletion from store-operated Ca(2+) entry. J Cell Biol 2002; 156(1): 75-85.
132. 2+ in isolated rat hepatocytes as measured by quin2. Effects of noradrena-line and vasopressin. FEBS Lett 1984; 167(1): 19-24.
133. Stathopulos PB, Zheng L, Ikura M. Stromal interaction molecule (STIM) 1 and STIM2 calcium sensing regions exhibit distinct unfolding and oligomerization kinetics. J Biol Chem 2009; 284(2): 728-732.
134. 2+ sensory region of STIM1 and STIM2. Biochem Biophys Res Commun 2008; 369(1): 240-246.
135. Mekahli D, Bultynck G, Parys JB, De Smedt H, Missiaen L. Endo-plasmic-reticulum calcium depletion and disease. Cold Spring Harbor Perspect Biol 2011; 3(6). pii: a004317. doi: 10.1101/cshperspect.a004317.
136. Darbellay B, Arnaudeau S, Ceroni D, Bader CR, Konig S, Bern-heim L. Human muscle economy myoblast differentiation and excitation-contraction coupling use the same molecular partners, STIM1 and STIM2. J Biol Chem 2010; 285(29): 22437-22447.
137. Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 2008; 9(4): 432-443.
138. 2+ levels. Cell 2007; 131(7): 1327-1339.
139. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990; 271(2): 515-522.
140. Franzius D, Hoth M, Penner R. Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch 1994; 428(5-6): 433-438.
141. Putney JW. Pharmacology of store-operated calcium channels. Mol Interventions 2010; 10(4): 209-218.
142. Mignen O, Brink C, Enfissi A, Nadkarni A, Shuttleworth TJ, Gio-vannucci DR, et al. Carboxyamidotriazole-induced inhibition of mi-tochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells. J Cell Sci 2005; 118(Pt 23): 5615-5623.
143. Gilabert JA, Parekh AB. Respiring mitochondria determine the pattern of activation and inactivation of the store-operated Ca(2+) current I(CRAC). EMBO J 2000; 19(23): 6401-6407.
144. Hoth M, Button DC, Lewis RS. Mitochondrial control of calcium-channel gating: A mechanism for sustained signaling and transcrip-tional activation in T lymphocytes. Proc Natl Acad Sci USA 2000; 97(19): 10607-10612.
145. Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, et al. Permeation and gating properties of the novel epithelial Ca(2+) channel. J Biol Chem 2000; 275(6): 3963-3969.
146. Sternfeld L, Krause E, Schmid A, Anderie I, Latas A, Al-Shaldi H, et al. Tyrosine phosphatase PTP1B interacts with TRPV6 in vivo and plays a role in TRPV6-mediated calcium influx in HEK293 cells. Cell Signal 2005; 17(8): 951-960.
147. Crunelli V, Toth TI, Cope DW, Blethyn K, Hughes SW. The 'window' T-type calcium current in brain dynamics of different behavioural states. J Physiol 2005; 562(Pt 1): 121-129.
148. Bean BP, McDonough SI. Two for T. Neuron 1998; 20(5): 825-828.
149. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 2002; 277(13): 10824-10833.
150. Kotturi MF, Hunt SV, Jefferies WA. Roles of CRAC and Cav-like channels in T cells: More than one gatekeeper? Trends Pharmacol Sci 2006; 27(7): 360-367.
151. Tokuoka S, Morioka H. The membrane potential of the human cancer and related cells. Gan 1957; 48(4): 353-354.
152. Binggeli R, Cameron IL. Cellular potentials of normal and cancerous fibroblasts and hepatocytes. Cancer Res 1980; 40(6): 1830-1835.
153. Capiod T. Cell proliferation, calcium influx and calcium channels. Biochimie 2011; 93(12): 2075-2079.
154. Becchetti A. Ion chennels and cell proliferation in cancer. Am J Physiol Cell Physiol 2011; 301(2): C255-C265.
155. Blackiston DJ, McLaughlin KA, Levin M. Bioelectric controls of cell proliferation: Ion channels, membrane voltage and the cell cycle. Cell Cycle 2009; 8(21): 3519-3528.
156. Steegmann-Olmedillas JL. The role of iron in tumour cell proliferation. Clin Transl Oncol 2011; 13(2): 71-76.
157. Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 2003; 1619(2): 113-124.
158. Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 1990; 75(10): 1903-1919.
159. Dreosti IE. Zinc and the gene. Mutat Res 2001; 475(1-2): 161-167.
160. Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001; 14(3-4): 331-341.
161. Pulido MD, Parrish AR. Metal-induced apoptosis: Mechanisms. Mutat Res 2003; 533(1-2): 227-241.
162. Hirata Y. Manganese-induced apoptosis in PC12 cells. Neurotoxi-col Teratol 2002; 24(5): 639-653.
163. Andrews NC. Disorders of iron metabolism. New Engl J Med 1999; 341(26): 1986-1995.
164. Buss JL, Greene BT, Turner J, Torti FM, Torti SV. Iron chelators in cancer chemotherapy. Curr Top Med Chem 2004; 4(15): 1623-1635.
165. Hershko C. Control of disease by selective iron depletion: A novel therapeutic strategy utilizing iron chelators. Bailliere Clin Haem 1994; 7(4): 965-1000.
166. Yu Y, Kovacevic Z, Richardson DR. Tuning cell cycle regulation with an iron key. Cell Cycle 2007; 6(16): 1982-1994.
167. Brodie C, Siriwardana G, Lucas J, Schleicher R, Terada N, Szepesi A, et al. Neuroblastoma sensitivity to growth inhibition by deferri-oxamine: Evidence for a block in G1 phase of the cell cycle. Cancer Res 1993; 53(17): 3968-3975.
168. Lucas JJ, Szepesi A, Domenico J, Takase K, Tordai A, Terada N, et al. Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: Selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase. Blood 1995; 86(6): 2268-2280.
169. Hileti D, Panayiotidis P, Hoffbrand AV. Iron chelators induce apop-tosis in proliferating cells. Brit J Haematol 1995; 89(1): 181-187.
170. Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: Alterations that facilitate proliferation? Crit Rev Oncol Hematol 2002; 42(1): 65-78.
171. Le NT, Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 2002; 1603(1): 31-46.
172. Renton FJ, Jeitner TM. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators. Bio-chem Pharmacol 1996; 51(11): 1553-1561.
173. Kalinowski DS, Richardson DR. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev 2005; 57(4): 547-583.
174. Chenoufi N, Baffet G, Drenou B, Cariou S, Desille M, Clement B, et al. Deferoxamine arrests in vitro the proliferation of porcine he-patocyte in G1 phase of the cell cycle. Liver 1998; 18(1): 60-66.
175. Chenoufi N, Drenou B, Loreal O, Pigeon C, Brissot P, Lescoat G. Antiproliferative effect of deferiprone on the Hep G2 cell line. Bio-chem Pharmacol 1998; 56(4): 431-437.
176. Okada T, Sawada T, Kubota K. Deferoxamine enhances anti-proliferative effect of interferon-gamma against hepatocellular carcinoma cells. Cancer Lett 2007; 248(1): 24-31.
177. Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E, et al. Antiproliferative and apoptotic effects of iron chela-tors on human cervical carcinoma cells. Gynecol Oncol 2002; 85(1): 95-102.
178. Hatcher HC, Singh RN, Torti FM, Torti SV. Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med Chem 2009; 1(9): 1643-1670.
179. Kontoghiorghes GJ, Efstathiou A, Ioannou-Loucaides S, Kolnagou A. Chelators controlling metal metabolism and toxicity pathways: Applications in cancer prevention, diagnosis and treatment. Hemoglobin 2008; 32(1-2): 217-227.
180. Capiod T. ATP-activated cation currents in single guinea-pig hepa-tocytes. J Physiol 1998; 507(Pt 3): 795-805.
181. Mwanjewe J, Grover AK. Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells. Biochem J 2004; 378(Pt 3): 975-982.
182. Kovacs G, Danko T, Bergeron MJ, Balazs B, Suzuki Y, Zsembery A, et al. Heavy metal cations permeate the TRPV6 epithelial cation channel. Cell Calcium 2011; 49(1): 43-55.
183. Gibon J, Tu P, Bohic S, Richaud P, Arnaud J, Zhu M, et al. The over-expression of TRPC6 channels in HEK-293 cells favours the intracellular accumulation of zinc. Biochim Biophys Acta 2011; 1808(12): 2807-2818.
184. Wagner TF, Drews A, Loch S, Mohr F, Philipp SE, Lambert S, et al. TRPM3 channels provide a regulated influx pathway for zinc in pancreatic beta cells. Pflugers Arch 2010; 460(4): 755-765.
185. Martineau C, Abed E, Medina G, Jomphe LA, Mantha M, Jumarie C, et al. Involvement of transient receptor potential melastatin-related 7 (TRPM7) channels in cadmium uptake and cytotoxicity in MC3T3-E1 osteoblasts. Toxicol Lett 2011; 199(3) 357-363.
186. Hoth M, Penner R. Calcium release-activated calcium current in rat mast cells. J Physiol 1993; 465: 359-386.
187. Fasolato C, Hoth M, Penner R. Multiple mechanisms of manganese-induced quenching of fura-2 fluorescence in rat mast cells. Pflugers Arch 1993; 423(3-4): 225-231.
188. Lee BC, Chu TK, Dill KA, Zuckermann RN. Biomimetic nanos-tructures: creating a high-affinity zinc-binding site in a folded non-biological polymer. J Am Chem Soc 2008; 130(27): 8847-8855.
189. Hasegawa H, Ichiyama A. Distinctive iron requirement of trypto-phan 5-monooxygenase: TPH1 requires dissociable ferrous iron. Biochem Biophys Res Commun 2005; 338(1): 277-284.
190. Murray A, Hunt T. The Cell Cycle. Oxford University Press: New York 1993.
191. Mignen O, Thompson JL, Shuttleworth TJ. Calcineurin directs the reciprocal regulation of calcium entry pathways in nonexcitable cells. J Biol Chem 2003; 278(41): 40088-40096.
192. Tomono M, Toyoshima K, Ito M, Amano H, Kiss Z. Inhibitors of calcineurin block expression of cyclins A and E induced by fibro-blast growth factor in Swiss 3T3 fibroblasts. Arch Biochem Bio-phys 1998; 353(2): 374-378.
193. Glassford J, Soeiro I, Skarell SM, Banerji L, Holman M, Klaus GG, et al. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene 2003; 22(15): 2248-2259.
194. Hickie RA, Wei JW, Blyth LM, Wong DY, Klaassen DJ. Cations and calmodulin in normal and neoplastic cell growth regulation. Can J Biochem Cell Biol 1983; 61(8): 934-941.
195. Means AR. Calcium, calmodulin and cell cycle regulation. FEBS Lett 1994; 347(1): 1-4.
196. 2+/CaM-dependent protein kinase cascade in health and disease. Sub-Cellular Biochem 2007; 45: 169-214.
197. Brown DA, London E. Functions of lipid rafts in biological membranes. Ann Rev Cell Develop Biol 1998; 14: 111-136.
198. Popescu LM, Diculescu I, Zelck U, Ionescu N. Ultrastructural distribution of calcium in smooth muscle cells of guinea-pig taenia coli. A correlated electron microscopic and quantitative study. Cell Tissue Res 1974; 154(3): 357-378.
199. Isshiki M, Ying YS, Fujita T, Anderson RG. A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 2002; 277(45): 43389-43398.
200. 2+-dependent signal transduction. Traffic 2003; 4(11): 717-723.
201. Duhon D, Bigelow RL, Coleman DT, Steffan JJ, Yu C, Langston W, et al. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol Carcinogen 2010; 49(8): 739-749.
202. Mineo C, James GL, Smart EJ, Anderson RG. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 1996; 271(20): 11930-11935.
203. Pike LJ. Growth factor receptors, lipid rafts and caveolae: An evolving story. Biochim Biophys Acta 2005;1746(3):260-273.
204. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 2009; 45(6): 625-633.
205. Pani B, Ong HL, Brazer SC, Liu X, Rauser K, Singh BB, et al. Activation of TRPC1 by STIM1 in ER-PM microdomains involves release of the channel from its scaffold caveolin-1. Proc Nat Acad Sci USA 2009; 106(47): 20087-20092.
206. 2+ influx channels by regulating plasma membrane localization of TRPC1. The J Biol Chem 2003; 278(29): 27208-27215.
207. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001; 294(5541): 333-339.
208. Wheeler DG, Barrett CF, Groth RD, Safa P, Tsien RW. CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. J Cell Biol 2008; 183(5): 849-863.
209. Cahalan MD, Zhang SL, Yeromin AV, Ohlsen K, Roos J, Stauder-man KA. Molecular basis of the CRAC channel. Cell Calcium 2007; 42(2): 133-144.
210. Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: Selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem 2010; 285(25): 19173-19183.
211. Malathi K, Li X, Krizanova O, Ondrias K, Sperber K, Ablamunits V, et al. Cdc2/cyclin B1 interacts with and modulates inositol 1,4,5-trisphosphate receptor (type 1) functions. J Immunol 2005; 175(9): 6205-6210.
212. Kaczmarek LK. Non-conducting functions of voltage-gated ion channels. Nat Rev Neurosci 2006; 7(10): 761-771.
213. Barbado M, Fablet K, Ronjat M, De Waard M. Gene regulation by voltage-dependent calcium channels. Biochim Biophys Acta 2009; 1793(6): 1096-1104.
214. 2+ channel beta subunits? Sci STKE 2005; 2005(275): pe11.
215. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R. The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 2006; 127(3): 591-606.
216. Huang CL. The transient receptor potential superfamily of ion channels. J Am Soc Nephrol 2004; 15(7): 1690-1699.
217. 2+nificent TRPM chanzymes. Curr Biol 2003; 13(20): R799-R801.
218. 2+ influx system mediated by LTRPC2. Science; 293(5533): 1327-1330.
219. Zhang W, Hirschler-Laszkiewicz I, Tong Q, Conrad K, Sun SC, Penn L, et al. TRPM2 is an ion channel that modulates hema-topoietic cell death through activation of caspases and PARP cleavage. Am J Physiol 2006; 290(4): C1146-C1159.
220. Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J Biol Chem 2005; 280(45): 37763-37771.
221. Lipskaia L, Hulot JS, Lompre AM. Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflugers Arch 2009; 457(3): 673-685.
222. 2+ATPase regulation. J Biol Chem 1996; 271(44): 27788-27794.
223. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 1993; 90(11): 4986-4990.
224. Waldron RT, Short AD, Meadows JJ, Ghosh TK, Gill DL. Endo-plasmic reticulum calcium pump expression and control of cell growth. J Biol Chem 1994; 269(16): 11927-11933.
225. 2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 2001; 276(50): 47608-47614.
226. Bergner A, Huber RM. Regulation of the endoplasmic reticulum Ca(2+)-store in cancer. Anticancer Agents Med Chem 2008; 8(7): 705-709.